Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Callaghan

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2014
Increased mortality persists in an adult drug-resistant epilepsy prevalence cohortBrian Callaghan, Hyunmi Choi, Malka Schlesinger, et al.
Journal of Diabetes and Its Complications|October 28, 2022
The conundrum of diabetic neuropathies-Past, present, and futureLynn Ang, Kara Mizokami-Stout, Stephanie A Eid, et al.
Journal of Diabetes and Its Complications|August 13, 2015
Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized studyMamta Jaiswal, Catherine L Martin, Morton B Brown, et al.
JAMA Network Open|May 17, 2021
Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 PandemicAdam de Havenon, John P Ney, Brian Callaghan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A Rapid Decrease in Stroke, Acute Coronary Syndrome, and Corresponding Interventions at 65 United States Hospitals Following Emergence of COVID-19Adam de Havenon, John Ney, Brian Callaghan, et al.
Journal of the Peripheral Nervous System : JPNS|May 18, 2026
Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab DebateGordon Sloan, Shazli Azmi, Stephanie Eid, et al.
Diabetes Technology & Therapeutics|April 9, 2016
Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor FunctionAaron I Vinik, A Gordon Smith, J Robinson Singleton, et al.
Journal of Medical Internet Research|February 5, 2025
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With CancerCiao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, et al.
Neurology|March 11, 2021
Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part DAdam de Havenon, Alen Delic, Sarah Dehoney, et al.
Journal of Health Communication|April 27, 2016
Communication Barriers and the Clinical Recognition of Diabetic Peripheral Neuropathy in a Diverse Cohort of Adults: The DISTANCE StudyAlyce S Adams, Melissa M Parker, Howard H Moffet, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2014
Increased mortality persists in an adult drug-resistant epilepsy prevalence cohortBrian Callaghan, Hyunmi Choi, Malka Schlesinger, et al.
Journal of Diabetes and Its Complications|October 28, 2022
The conundrum of diabetic neuropathies-Past, present, and futureLynn Ang, Kara Mizokami-Stout, Stephanie A Eid, et al.
Journal of Diabetes and Its Complications|August 13, 2015
Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized studyMamta Jaiswal, Catherine L Martin, Morton B Brown, et al.
JAMA Network Open|May 17, 2021
Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 PandemicAdam de Havenon, John P Ney, Brian Callaghan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
A Rapid Decrease in Stroke, Acute Coronary Syndrome, and Corresponding Interventions at 65 United States Hospitals Following Emergence of COVID-19Adam de Havenon, John Ney, Brian Callaghan, et al.
Journal of the Peripheral Nervous System : JPNS|May 18, 2026
Clinical Diabetic Peripheral Neuropathy: Can It Be Reversed? Arguments for and Against From a NEUROdiab DebateGordon Sloan, Shazli Azmi, Stephanie Eid, et al.
Diabetes Technology & Therapeutics|April 9, 2016
Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor FunctionAaron I Vinik, A Gordon Smith, J Robinson Singleton, et al.
Journal of Medical Internet Research|February 5, 2025
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With CancerCiao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, et al.
Neurology|March 11, 2021
Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part DAdam de Havenon, Alen Delic, Sarah Dehoney, et al.
Journal of Health Communication|April 27, 2016
Communication Barriers and the Clinical Recognition of Diabetic Peripheral Neuropathy in a Diverse Cohort of Adults: The DISTANCE StudyAlyce S Adams, Melissa M Parker, Howard H Moffet, et al.
Pageof 4